| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Ophthalmology, University of Texas Health Science Center at San Antonio, San Antonio, Texas; the 3 Department of Physiology, University of Vienna Medical School, Vienna, Austria; the 2 Wilmer Ophthalmological Institute, the 4 Dana Center for Preventive Ophthalmology, and the 5 Departments of Molecular Biology and Genetics and Neuroscience, Johns Hopkins University School of Medicine, Baltimore, Maryland.
PURPOSE. Retinal ganglion cell (RGC) death in glaucoma involves apoptosis. Activation of caspases and abnormal processing of amyloid precursor protein (APP) are important events in other chronic neurodegenerations, such as Alzheimer’s disease (AD). The retinal expression and activation of caspases and the patterns of caspase-3–mediated APP processing in ocular hypertensive models of rat glaucoma were investigated.
METHODS. RGC death was produced in one eye by chronic exposure to increased intraocular pressure (IOP) or by optic nerve transection. Elevated IOP was produced by obstruction of aqueous humor outflow with laser coagulation or limbal hypertonic saline injection. Caspase activity and APP processing in the retina were examined by RNase protection assay (RPA), immunocytochemistry, immunoblot assay, and colorimetric assay.
RESULTS. RPA revealed elevations of caspase-3 mRNA, as well as other apoptosis-related mRNAs. Immunocytochemistry showed caspase-3 activation in RGCs damaged by ocular hypertension. The generation of the caspase-3–mediated APP cleavage product (
C-APP) was also increased in ocular hypertensive RGCs. Western immunoblot assay and colorimetry revealed significantly more activated caspase-3 in ocular hypertensive retinas than in control retinas. The activated form of caspase-8, an initiator caspase, and amyloid-ß, a product of APP proteolysis and a component of senile plaques in AD, were detected in RGCs by immunohistochemistry significantly more often in ocular hypertensive than in control retinas. The amounts of full-length APP were reduced and amyloid-ß–containing fragments were increased in ocular hypertensive retinas by Western immunoblot assay.
CONCLUSIONS. Rat RGCs subjected to chronic ocular hypertension demonstrate caspase activation and abnormal processing of APP, which may contribute to the pathophysiology of glaucoma.
This article has been cited by other articles:
|
|
 |
|
  D. Goldblum, A. Kipfer-Kauer, G.-M. Sarra, S. Wolf, and B. E. Frueh Distribution of Amyloid Precursor Protein and Amyloid-{beta} Immunoreactivity in DBA/2J Glaucomatous Mouse Retinas Invest. Ophthalmol. Vis. Sci., November 1, 2007; 48(11): 5085 - 5090. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Liu, W.-K. Ju, J. G. Crowston, F. Xie, G. Perry, M. A. Smith, J. D. Lindsey, and R. N. Weinreb Oxidative Stress Is an Early Event in Hydrostatic Pressure Induced Retinal Ganglion Cell Damage Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4580 - 4589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cantarella, C. Bucolo, G. Di Benedetto, S. Pezzino, L. Lempereur, R. Calvagna, S. Clementi, P. Pavone, L. Fiore, and R. Bernardini Protective effects of the sigma agonist Pre-084 in the rat retina Br. J. Ophthalmol., October 1, 2007; 91(10): 1382 - 1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Guo, T. E. Salt, V. Luong, N. Wood, W. Cheung, A. Maass, G. Ferrari, F. Russo-Marie, A. M. Sillito, M. E. Cheetham, et al. Targeting amyloid-beta in glaucoma treatment PNAS, August 14, 2007; 104(33): 13444 - 13449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Danesh-Meyer, H. Birch, J. Y.-F. Ku, S. Carroll, and G. Gamble Reduction of optic nerve fibers in patients with Alzheimer disease identified by laser imaging Neurology, November 28, 2006; 67(10): 1852 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Li, B.-Y. Chen, D. K. Tay, H. H. L. Chan, M.-L. Pu, and K.-F. So Melanopsin-expressing retinal ganglion cells are more injury-resistant in a chronic ocular hypertension model. Invest. Ophthalmol. Vis. Sci., July 1, 2006; 47(7): 2951 - 2958. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Levkovitch-Verbin, R. Dardik, S. Vander, Y. Nisgav, M. Kalev-Landoy, and S. Melamed Experimental glaucoma and optic nerve transection induce simultaneous upregulation of proapoptotic and prosurvival genes. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2491 - 2497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Levkovitch-Verbin, M. Kalev-Landoy, Z. Habot-Wilner, and S. Melamed Minocycline delays death of retinal ganglion cells in experimental glaucoma and after optic nerve transection. Arch Ophthalmol, April 1, 2006; 124(4): 520 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. P. McKernan, C. Caplis, M. Donovan, C. J. O'Brien, and T. G. Cotter Age-dependent susceptibility of the retinal ganglion cell layer to cell death. Invest. Ophthalmol. Vis. Sci., March 1, 2006; 47(3): 807 - 814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tezel, X. Yang, and J. Cai Proteomic Identification of Oxidatively Modified Retinal Proteins in a Chronic Pressure-Induced Rat Model of Glaucoma Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3177 - 3187. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Huang, A. Dobberfuhl, T. Filippopoulos, M. Ingelsson, J. B. Fileta, N. R. Poulin, and C. L. Grosskreutz Transcriptional Up-Regulation and Activation of Initiating Caspases in Experimental Glaucoma Am. J. Pathol., September 1, 2005; 167(3): 673 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Huang, J. B. Fileta, A. Dobberfuhl, T. Filippopolous, Y. Guo, G. Kwon, and C. L. Grosskreutz Calcineurin cleavage is triggered by elevated intraocular pressure, and calcineurin inhibition blocks retinal ganglion cell death in experimental glaucoma PNAS, August 23, 2005; 102(34): 12242 - 12247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. A. Quigley Glaucoma: Macrocosm to Microcosm The Friedenwald Lecture Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2663 - 2670. [Full Text] [PDF]
|
|
|
|
|
|
G. Tezel and X. Yang Caspase-Independent Component of Retinal Ganglion Cell Death, In Vitro Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4049 - 4059. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. F. Cordeiro, L. Guo, V. Luong, G. Harding, W. Wang, H. E. Jones, S. E. Moss, A. M. Sillito, and F. W. Fitzke Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration PNAS, September 7, 2004; 101(36): 13352 - 13356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. A. El-Asrar, L. Dralands, L. Missotten, I. A. Al-Jadaan, and K. Geboes Expression of Apoptosis Markers in the Retinas of Human Subjects with Diabetes Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2760 - 2766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Weishaupt, G. Rohde, E. Polking, A.-L. Siren, H. Ehrenreich, and M. Bahr Effect of Erythropoietin Axotomy-Induced Apoptosis in Rat Retinal Ganglion Cells Invest. Ophthalmol. Vis. Sci., May 1, 2004; 45(5): 1514 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ahmed, K. M. Brown, D. A. Stephan, J. C. Morrison, E. C. Johnson, and S. I. Tomarev Microarray Analysis of Changes in mRNA Levels in the Rat Retina after Experimental Elevation of Intraocular Pressure Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1247 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Guimaraes, M. Benchimol, G. P. Amarante-Mendes, and R. Linden Alternative Programs of Cell Death in Developing Retinal Tissue J. Biol. Chem., October 24, 2003; 278(43): 41938 - 41946. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. N. Zacks, V. Hanninen, M. Pantcheva, E. Ezra, C. Grosskreutz, and J. W. Miller Caspase Activation in an Experimental Model of Retinal Detachment Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1262 - 1267. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
